Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Vitamin D in Vascular Calcification: A Double-Edged Sword?

Wang J, Zhou JJ, Robertson GR, Lee VW.

Nutrients. 2018 May 22;10(5). pii: E652. doi: 10.3390/nu10050652. Review.

2.

Lipolytic and thermogenic depletion of adipose tissue in cancer cachexia.

Tsoli M, Swarbrick MM, Robertson GR.

Semin Cell Dev Biol. 2016 Jun;54:68-81. doi: 10.1016/j.semcdb.2015.10.039. Epub 2015 Oct 31. Review.

PMID:
26529279
3.

Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signalling.

Kacevska M, Mahns A, Sharma R, Clarke SJ, Robertson GR, Liddle C.

Pharm Res. 2013 Sep;30(9):2270-8. doi: 10.1007/s11095-013-1042-3. Epub 2013 Apr 20.

PMID:
23604979
4.

HNF4α: a new biomarker in colon cancer?

Chellappa K, Robertson GR, Sladek FM.

Biomark Med. 2012 Jun;6(3):297-300. doi: 10.2217/bmm.12.23. No abstract available.

5.

Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting.

Shum AM, Mahendradatta T, Taylor RJ, Painter AB, Moore MM, Tsoli M, Tan TC, Clarke SJ, Robertson GR, Polly P.

Aging (Albany NY). 2012 Feb;4(2):133-43.

6.

Src tyrosine kinase phosphorylation of nuclear receptor HNF4α correlates with isoform-specific loss of HNF4α in human colon cancer.

Chellappa K, Jankova L, Schnabl JM, Pan S, Brelivet Y, Fung CL, Chan C, Dent OF, Clarke SJ, Robertson GR, Sladek FM.

Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2302-7. doi: 10.1073/pnas.1106799109. Epub 2012 Jan 30.

7.

Classification of cancer patients using pathway analysis and network clustering.

Fung DC, Lo A, Jankova L, Clarke SJ, Molloy M, Robertson GR, Wilkins MR.

Methods Mol Biol. 2011;781:311-36. doi: 10.1007/978-1-61779-276-2_15.

PMID:
21877288
8.

Proteomic comparison of colorectal tumours and non-neoplastic mucosa from paired patient samples using iTRAQ mass spectrometry.

Jankova L, Chan C, Fung CL, Song X, Kwun SY, Cowley MJ, Kaplan W, Dent OF, Bokey EL, Chapuis PH, Baker MS, Robertson GR, Clarke SJ, Molloy MP.

Mol Biosyst. 2011 Nov;7(11):2997-3005. doi: 10.1039/c1mb05236e. Epub 2011 Aug 2.

PMID:
21808808
9.

Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism.

Kacevska M, Downes MR, Sharma R, Evans RM, Clarke SJ, Liddle C, Robertson GR.

Clin Cancer Res. 2011 May 15;17(10):3170-80. doi: 10.1158/1078-0432.CCR-10-3289. Epub 2011 Apr 15.

10.

Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.

Lee A, Chick JM, Kolarich D, Haynes PA, Robertson GR, Tsoli M, Jankova L, Clarke SJ, Packer NH, Baker MS.

Mol Cell Proteomics. 2011 Sep;10(9):M900538MCP200. doi: 10.1074/mcp.M900538-MCP200. Epub 2010 Feb 18.

11.

The alternatively spliced murine pregnane X receptor isoform, mPXR(delta171-211) exhibits a repressive action.

Matic M, Corradin AP, Tsoli M, Clarke SJ, Polly P, Robertson GR.

Int J Biochem Cell Biol. 2010 May;42(5):672-82. doi: 10.1016/j.biocel.2010.01.001. Epub 2010 Jan 11.

PMID:
20060928
12.

A novel approach to investigate the subcellular distribution of nuclear receptors in vivo.

Matic M, Nakhel S, Lehnert AM, Polly P, Clarke SJ, Robertson GR.

Nucl Recept Signal. 2009 May 8;7:e004. doi: 10.1621/nrs.07004.

13.

Pharmacogenetics of pharmacoecology: which route to personalized medicine?

Robertson GR, Grant DM, Piquette-Miller M.

Clin Pharmacol Ther. 2009 Apr;85(4):343-8. doi: 10.1038/clpt.2009.17. No abstract available.

PMID:
19295529
14.

Inflammation and altered drug clearance in cancer: transcriptional repression of a human CYP3A4 transgene in tumor-bearing mice.

Robertson GR, Liddle C, Clarke SJ.

Clin Pharmacol Ther. 2008 Jun;83(6):894-7. doi: 10.1038/clpt.2008.55. Epub 2008 Mar 26. Review.

PMID:
18388870
15.

Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosing.

Kacevska M, Robertson GR, Clarke SJ, Liddle C.

Expert Opin Drug Metab Toxicol. 2008 Feb;4(2):137-49. doi: 10.1517/17425255.4.2.137. Review.

PMID:
18248309
16.

Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer.

Morgan ET, Goralski KB, Piquette-Miller M, Renton KW, Robertson GR, Chaluvadi MR, Charles KA, Clarke SJ, Kacevska M, Liddle C, Richardson TA, Sharma R, Sinal CJ.

Drug Metab Dispos. 2008 Feb;36(2):205-16. doi: 10.1124/dmd.107.018747.

PMID:
18218849
17.

Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer.

Charles KA, Rivory LP, Brown SL, Liddle C, Clarke SJ, Robertson GR.

Clin Cancer Res. 2006 Dec 15;12(24):7492-7.

18.

Pregnane X receptor: promiscuous regulator of detoxification pathways.

Matic M, Mahns A, Tsoli M, Corradin A, Polly P, Robertson GR.

Int J Biochem Cell Biol. 2007;39(3):478-83. Epub 2006 Sep 14. Review.

PMID:
17188925
19.

Pretranslational upregulation of microsomal CYP4A in rat liver by intake of a high-sucrose, lipid-devoid diet containing orotic acid.

Su GM, Fiala-Beer E, Weber J, Jahn D, Robertson GR, Murray M.

Biochem Pharmacol. 2005 Feb 15;69(4):709-17. Epub 2004 Dec 23.

PMID:
15670589
20.

Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.

McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC.

Hepatology. 2004 Aug;40(2):386-93.

PMID:
15368443
21.

Transgenic mouse models of human CYP3A4 gene regulation.

Robertson GR, Field J, Goodwin B, Bierach S, Tran M, Lehnert A, Liddle C.

Mol Pharmacol. 2003 Jul;64(1):42-50.

PMID:
12815159
22.

Predicting inductive drug-drug interactions.

Liddle C, Robertson GR.

Pharmacogenomics. 2003 Mar;4(2):141-52. Review.

PMID:
12605548
23.

Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor.

Goodwin B, Hodgson E, D'Costa DJ, Robertson GR, Liddle C.

Mol Pharmacol. 2002 Aug;62(2):359-65.

PMID:
12130689
24.

Leptin is essential for the hepatic fibrogenic response to chronic liver injury.

Leclercq IA, Farrell GC, Schriemer R, Robertson GR.

J Hepatol. 2002 Aug;37(2):206-13.

PMID:
12127425
25.

Liver regeneration in obese mice with fatty livers: does the impairment have relevance for other types of fatty liver disease?

Farrell GC, Robertson GR, Leclercq I, Horsmans Y.

Hepatology. 2002 Mar;35(3):731-2. No abstract available.

PMID:
11870394
26.

CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.

Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR.

J Clin Invest. 2000 Apr;105(8):1067-75.

27.

Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob/ob mice.

Leclercq IA, Field J, Enriquez A, Farrell GC, Robertson GR.

Biochem Biophys Res Commun. 2000 Feb 16;268(2):337-44.

PMID:
10679205
28.

Sexually dimorphic expression of rat CYP3A9 and CYP3A18 genes is regulated by growth hormone.

Robertson GR, Farrell GC, Liddle C.

Biochem Biophys Res Commun. 1998 Jan 6;242(1):57-60.

PMID:
9439609
29.

Differential block coding of bilevel images.

Robertson GR, Aburdene MF, Kozick RJ.

IEEE Trans Image Process. 1996;5(9):1368-70.

PMID:
18285226
30.

Optical waveguide laser using an rf sputtered Nd:glass film.

Robertson GR, Jessop PE.

Appl Opt. 1991 Jan 20;30(3):276-8. doi: 10.1364/AO.30.000276.

PMID:
20581978
31.

Sequence characteristics of a gene in equine herpesvirus 1 homologous to glycoprotein H of herpes simplex virus.

Robertson GR, Scott NA, Miller JM, Sabine M, Zheng M, Bell CW, Whalley JM.

DNA Seq. 1991;1(4):241-9.

PMID:
1666854
32.

Identification and nucleotide sequence of a gene in equine herpesvirus 1 analogous to the herpes simplex virus gene encoding the major envelope glycoprotein gB.

Whalley JM, Robertson GR, Scott NA, Hudson GC, Bell CW, Woodworth LM.

J Gen Virol. 1989 Feb;70 ( Pt 2):383-94. Erratum in: J Gen Virol 1989 Dec;70(Pt 12):3513.

PMID:
2543744
34.

Malignant hyperthermia.

Robertson GR.

J Can Dent Assoc. 1987 Jan;53(1):33-5. No abstract available.

PMID:
3545400
35.
36.

Differentiation of sub-types of equine herpesvirus I by restriction endonuclease analysis.

Sabine M, Robertson GR, Whalley JM.

Aust Vet J. 1981 Mar;57(3):148-9. No abstract available.

PMID:
6266385
37.

A bizarre manifestation of polyostotic fibrous dysplasia of the facial bones.

Robertson GR.

Int J Oral Surg. 1981;10(Suppl 1):47-51.

PMID:
6807907
38.

Primary malignant melanoma of the mouth.

Robertson GR, DeFiebre BK, Firtell DN.

J Oral Surg. 1979 May;37(5):349-52.

PMID:
285244
39.

Cleidocranial dysostosis with mandibular cyst. Report of a case.

Oatis GW, Robertson GR, Sugg WE, Firtell DN.

Oral Surg Oral Med Oral Pathol. 1975 Jul;40(1):62-7.

PMID:
1097984
40.

Dermoid cyst of the floor of the mouth. Report of a case.

Oatis GW Jr, Hartmen GL, Robertson GR, Sugg WE.

Oral Surg Oral Med Oral Pathol. 1975 Feb;39(2):192-6.

PMID:
1054446
41.

Compound dermoid cyst of the floor of the month.

Mosby EL, Robertson GR, Sugg WE Jr.

J Oral Surg. 1974 Aug;32(8):601-3. No abstract available.

PMID:
4526314
42.

Oral psoriasis.

Salmon TN, Robertson GR Jr, Tracy NH Jr, Hiatt WR.

Oral Surg Oral Med Oral Pathol. 1974 Jul;38(1):48-54. No abstract available.

PMID:
4525672
43.

Metastatic carcinoma of the mandibular condyle: report of case.

Hartman GL, Robertson GR, Sugg WE Jr, Hiatt WR.

J Oral Surg. 1973 Sep;31(9):716-7. No abstract available.

PMID:
4516030
44.

CHEMISTRY AT LOS ANGELES.

Robertson GR.

Science. 1925 Aug 21;62(1599):x. No abstract available.

PMID:
17839377

Supplemental Content

Loading ...
Support Center